- Datametrex AI (DM) has introduced telemedicine services via their Medi-Call mobile telehealth application
- The Medi-Call app will initially be available in BC, expanding to other provinces over the next several months
- Marshall Gunter, CEO of Datametrex sat down with Dave Jackson to discuss the news
- Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy
- Shares of Datametrex AI Limited (DM) opened trading at C$0.165
Datametrex AI (DM) has introduced telemedicine services via their Medi-Call mobile telehealth application.
Over the last few weeks, the team has been working hard to finalize the beta testing of the Medi-Call app with a select group of physicians and end-users.
Highlights
- The Medi-Call app will be available in English and French initially in the province of BC.
- The team will begin expanding geographic coverage over the next several months.
- Beta testing has helped the team achieve a fully functional mobile application that will be available for both Apple iOS and Android (full availability dates to be announced).
Marshall Gunter, CEO of Datametrex sat down with Dave Jackson to discuss the news.
“We are beyond excited to complete our beta testing and start introducing Med-Call to the Canadian market where there is an immediate need for faster access to healthcare.”
Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy.
Shares of Datametrex AI Limited (DM) opened trading at C$0.165.
